Interleukin-30: A novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury - Dibra, Denada; Cutrera, Jeffry; Xia, Xueqing; Kallakury, Bhaskar; Mishra, Lopa; Li, Shulin (Hepatology (Baltimore, Md.), 2012)
Keywords: Animals; Biological and medical sciences; Bones, joints and connective tissue. Antiinflammatory agents; Chemical and Drug Induced Liver Injury - prevention & control; Chemical and Drug Induced Liver Injury - therapy; Concanavalin A - adverse effects; Cytokines; Cytokines - adverse effects; Disease Models, Animal; Gastroenterology. Liver. Pancreas. Abdomen; Genetic Therapy; Hepatology; Humans; In Vitro Techniques; Inflammation; Interferon-gamma - adverse effects; Interferon-gamma - metabolism; Interleukin-12 - adverse effects; Interleukin-12 - genetics; Interleukin-12 - metabolism; Interleukins - genetics; Interleukins - metabolism; Liver; Liver - metabolism; Liver - pathology; Liver. Biliary tract. Portal circulation. Exocrine pancreas; Medical sciences; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Minor Histocompatibility Antigens; Pharmacology. Drug treatments; Receptors, Cytokine - deficiency; Receptors, Cytokine - genetics; Receptors, Interleukin; STAT1 Transcription Factor - deficiency; STAT1 Transcription Factor - genetics; Prevention; Treatment; Liver; Interleukin; Antiinflammatory agent; Cytokine; Gastroenterology